Biological activity of lignicolous marine micromycetes isolated from palmar's mangrove - provincia de santa Elena

Authors

  • Xavier Álvarez Montero University of Guayaquil
  • Nancy Saltos Rosero University of Guayaquil
  • Washington Cárdenas Escuela Superior Politécnica del Litoral

DOI:

https://doi.org/10.53591/iti.v3i3.109

Keywords:

Ascomycetes, secondary metabolites, bioactivity

Abstract

Marine fungi are a group of microorganisms capable of biosynthesized metabolites with novel structures. Generally microbial population produces compounds that work against the growth of other populations. Antibiotics produced naturally by these populations, could provide benefits in the control of diseases, both in aquaculture and in human and animal pathology, in this context tropical fungi are entering in screening programs as potential producers of drugs with new models of action. In the present investigation two protocols were established to evaluate the bioactivity ofmarine fungi against Gram positive and Gram negative bacteria: fungal extracts and fungal discs. There was no bioactivity in bioassays offungal extracts ofmarine ascomycete versus Gram negative bacteria Rhodospirillum sp. and Pseudomonas sp. Methods of preservation to fungal extracts at 4 and -20ºC were suitable for conservation, there was no loss of volume or change in color of the extracts or any other signs of deterioration, there was no fungal or bacterial contamination. None of fungal discs bioassays of marine ascomycetes versus Gram negative bacteria Enterobacter sp, Escherichia coli, E. coli001, Klebsiella sp., Klebsiella sp.001, and the Gram positive bacterium Staphylococcus sp. were observed inhibition of bacterial growth.

References

BAUER, A., W. KIRBY, l. SHERRIS & M. TURK 1966. Antibiotic susceptibility testing by standardized single disk method. Am. J. Clin. Pathol. 45: 493-496.

CHEN G., Y. LIN, L. WEN, L. VRIJMOEDC and E. GARETH JONESC 2003. Two new metabolites of a marine endophytic fungus (no. 1893) from an estuarine mangrove on the south China sea coast. Tetrahedron, 59: 4907-4909.

DAMARE, S 2006. Deep - sea fungi as a source of alkaline and cold - tolerant proteases. National Institute ofüceanography- Dona Paula, Goa - India.

KOSTA, S., JAIN, R. and TIWARI, A 2008. Marine Fungi: Potential source of pharmacological compound. Department ofBiotechnology-Gour University -India.

KROHN K. y M. RIAZ 2004. Total synthesis of (+) xyloketal D, a secondary metabolite from the mangrove fungus Xylaria sp. Tetrahedron Letters 45: 293-294.

LIN, Y., X. WU, Z. DENG, J. WANG, S. ZHOU, L. VRIJMOED and E. GARETH JONES 2002. The metabolites of the mangrove fungus Verruculina enalia No.2606 from a salt lake in the Bahamas. Phytochemistry 59: 469-471.

MAHDY,A2004. Secondarymetabolites of marine derived fungi: Natural product Chemistry and Biological Activity. Mathematisch-Naturwissenschaftlichen Fakultat der Rheinischen Friedrich-Wilhelms-Universitat Bonn.

MAHYUNDIN, N 2008. Actinomycetes and Fungi associated with marine invertebrates: A potential source of bioactive compounds. University of Canterbury Christchurch - New Zealand.

MORAINE, R. A. & ROGOVIN, P 1966. Kinetics of polysaccharide B-1459 fermentation, Biotechnol Bioengin. 8: 511-524.

PUNYASLOKE, B., BALSAM, T.M. and WRJGHT, P.C 2006. The current status of natural products from marine fungi and their potential as anti-infective agents. Plymouth Marine Laboratory - UK.

RAGHUKUMAR, C 2008. Marine fungal biotechnology: an ecological perspective. National Institute ofüceanography- Dona Paula, Goa - India.

ZU-JIAN, W., MING-AN, O. and QUING-WEI, T 2008. New asperxanthone and asperbiphenyl from the marine fungus Aspergillus sp. Institute of Plant Yirology, Fujan Agriculture and Forestry University, Fuzhou Fujian - PR China.

Published

2011-12-30

Issue

Section

Artículos